Board-certified podiatric surgeon & foot specialist | Balance Foot & Ankle
Last reviewed: May 2026
Diabetic peripheral neuropathy is the most common serious complication of diabetes — and the one that most directly threatens your feet, your mobility, and in the most severe cases, your lower limbs. It affects approximately 50% of people with diabetes, increases with disease duration, and is the underlying driver of 85% of all diabetes-related lower extremity amputations.
Yet in our podiatry practice, we regularly see patients who have had diabetes for 10, 15, even 20 years and were never told to specifically monitor for neuropathy, never had a monofilament test, and never received guidance on the foot examination protocol that can identify a wound before it becomes a crisis. That’s what this guide is for.
What Is Diabetic Peripheral Neuropathy?
Peripheral neuropathy means damage to the peripheral nervous system — the nerves that carry signals between the brain/spinal cord and the rest of the body. In diabetes, this damage is caused by the toxic effect of chronic hyperglycemia (high blood sugar) on nerve cells and the blood vessels that supply them. The peripheral nerves are particularly vulnerable because they are long, metabolically demanding structures with poor repair capacity.
The pattern of damage follows the “length-dependent” principle: the longest nerve fibers are affected first. This is why DPN begins in the toes and feet before it affects the hands — the nerve fibers running to the feet are simply longer and therefore more vulnerable. As the disease progresses, the sensory loss rises proximally: toes first, then feet, ankles, then lower legs in a classic “stocking” distribution. Eventually the hands develop similar changes — the “stocking-glove” pattern diagnostic of DPN.
The nerve damage in DPN is predominantly axonal — the nerve fibers themselves degenerate — with secondary demyelination (loss of the myelin sheath that insulates nerve fibers). Both small nerve fibers (responsible for pain and temperature sensation, and autonomic function) and large nerve fibers (responsible for vibration and proprioception) can be affected, though small fiber neuropathy is often the initial and predominant form.
Types of Diabetic Neuropathy
DPN is the most common form, but diabetes causes several types of neuropathy:
Distal symmetric peripheral neuropathy (DSPN). The classic DPN — bilateral, symmetrical, length-dependent sensorimotor neuropathy. This is what most people mean when they say “diabetic neuropathy.” It affects the feet first, progresses slowly, and is the primary driver of diabetic foot complications.
Autonomic neuropathy. Damage to the autonomic nerves controlling blood vessels, sweat glands, and gut function. In the foot, autonomic DPN causes reduced sweating (leading to dry, cracked skin — a portal for bacterial entry), reduced vasomotor control (affecting wound healing), and arteriovenous shunting. Autonomic neuropathy is why diabetic feet often feel warm and dry even when circulation is impaired at the capillary level.
Proximal neuropathy (diabetic amyotrophy). A more acute, often painful neuropathy affecting the thighs and hips — not the feet primarily. This form is associated with weight loss and can paradoxically occur when blood sugar improves rapidly.
Mononeuropathy. Sudden-onset weakness or pain in a single nerve distribution — most commonly the common peroneal nerve (foot drop), the femoral nerve, or the oculomotor nerve. These are related to microvascular ischemia of an individual nerve trunk and often improve partially over months.
Symptoms & Stages
DPN presents on a spectrum from asymptomatic to severely painful, and counterintuitively, less sensation is often more dangerous than more pain:
Early (small fiber predominantly): Burning, tingling, or “pins and needles” in the toes and forefoot. Hypersensitivity — even light touch or bedsheets feel painful (allodynia). This “positive symptom” phase, while uncomfortable, is actually the stage at which protective sensation is still somewhat intact.
Intermediate: The burning and tingling coexist with areas of reduced sensation. Sharp vs. dull discrimination begins to fail. Patients may not feel a pebble in their shoe, a blister forming, or a cut on the plantar surface. This is the dangerous transition zone.
Advanced: Loss of protective sensation (LOPS) — defined as inability to feel the 10-gram monofilament at standard testing sites. At this stage, patients have no warning signal for foot injuries. Autonomic involvement produces dry skin, fissuring, and absent sweating. Motor fiber damage causes intrinsic minus foot deformity — clawing of the toes, prominence of metatarsal heads, loss of the plantar fat pad. The foot is now at extreme risk for ulceration.
Severe/complicated: Charcot neuroarthropathy (acute collapse of the foot’s bony architecture, triggered by loss of protective sensation and autonomic dysfunction), non-healing ulcers, osteomyelitis, and ultimately amputation risk if management fails.
Why Diabetes Damages Nerves
The mechanism of nerve damage in diabetes is multifactorial — several pathways operate simultaneously:
Polyol pathway activation. High intracellular glucose is converted to sorbitol by aldose reductase, accumulating in Schwann cells (the cells that produce myelin) and nerve fibers. Sorbitol accumulation causes osmotic stress and depletes myoinositol, impairing nerve conduction.
Advanced glycation end-products (AGEs). Chronic hyperglycemia causes glucose to non-enzymatically bind to proteins, producing AGEs that damage the structural proteins of nerve fibers and the basement membrane of the microvasculature supplying nerves.
Oxidative stress. Excess glucose metabolism generates reactive oxygen species (free radicals) that directly damage neuronal mitochondria, impairing the neuron’s energy supply.
Microvascular ischemia. The same microangiopathy that damages the retina and kidney also affects the vasa nervorum — the tiny blood vessels that supply peripheral nerves. Ischemia (reduced blood flow) deprives nerve fibers of oxygen and nutrients.
Neuroinflammation. Chronic low-grade inflammatory signaling in diabetic patients contributes to neuronal dysfunction and is an emerging therapeutic target.
Diagnosis
Monofilament testing. The 10-gram Semmes-Weinstein monofilament is the most important screening tool for loss of protective sensation. The filament is pressed against standard sites on the plantar foot until it buckles — generating 10 grams of force. Inability to feel this at any site indicates LOPS. The ADA recommends annual monofilament testing for all patients with diabetes, starting at diagnosis for Type 2 (which may have been present years before formal diagnosis) and at 5 years post-diagnosis for Type 1.
Vibration testing. A 128 Hz tuning fork applied to the dorsum of the great toe assesses large fiber function. Loss of vibration sense is an early indicator of large-fiber neuropathy — predictive of progressive neuropathy and Charcot risk.
Ankle reflexes. Loss of the Achilles tendon reflex is an early clinical sign of DPN. Combined with vibration loss and monofilament deficit, it constitutes a clinically significant neuropathy finding.
Nerve conduction studies (NCS) and EMG. The gold standard for confirming and characterizing neuropathy — distinguishing axonal from demyelinating, quantifying severity, and ruling out other causes. Particularly important when atypical features exist: rapid progression, asymmetry, or significant motor involvement.
Skin punch biopsy (intraepidermal nerve fiber density). The gold standard for small fiber neuropathy diagnosis — NCS tests large fibers and may be normal in pure small fiber neuropathy. Biopsy quantifies the density of small unmyelinated fibers in the skin, reduced in DPN.
Ruling out non-diabetic causes. Not all neuropathy in diabetic patients is diabetic — B12 deficiency (especially in metformin users), hypothyroidism, renal disease, celiac disease, alcohol, medication toxicity (chemotherapy), vasculitis, and hereditary neuropathies must be excluded, particularly in atypical presentations.
Treatment Options
The Foundation: Glycemic Control
The only proven disease-modifying intervention for DPN is glycemic control. In Type 1 diabetes, the DCCT trial demonstrated that intensive insulin therapy (HbA1c target under 7%) reduced the development of neuropathy by 60% and its progression by 57%. In Type 2 diabetes, the evidence for intensive glycemic control specifically preventing neuropathy is less robust but consistent in direction — improving HbA1c reduces the rate of new neuropathy development.
What glycemic control cannot do: reverse established nerve damage. The structural damage to nerve fibers — axonal loss, demyelination — once present, does not significantly recover even with optimal glucose management. This is why early detection and early glycemic optimization matter so much. The goal is to protect the nerve fibers that remain, not to restore those already lost.
FDA-Approved Medications for Painful DPN
Duloxetine (Cymbalta). A serotonin-norepinephrine reuptake inhibitor (SNRI) and the first medication FDA-approved specifically for diabetic neuropathic pain. Works by enhancing descending pain inhibition pathways in the spinal cord. Effective dose: 60–120mg daily. Most common side effects: nausea (usually transient), dry mouth, constipation, insomnia. Onset of pain relief: 1–2 weeks. Good first choice, especially for patients with comorbid depression or anxiety.
Pregabalin (Lyrica). Alpha-2-delta calcium channel ligand, FDA-approved for DPN pain. Reduces the abnormal firing of sensitized pain neurons. Effective dose: 150–600mg daily in divided doses. Side effects: sedation, dizziness, weight gain, peripheral edema. Onset: 1 week. A controlled substance (Schedule V) in the US due to abuse potential. Better tolerability profile than gabapentin for many patients.
Evidence-Based Off-Label Medications
Gabapentin (Neurontin). Not FDA-approved for DPN but widely used and evidence-supported. Same mechanism as pregabalin, requires more frequent dosing (3 times daily), with high variability in absorption. Effective dose varies widely: 900–3600mg daily. Cost-effective generic option. Side effects similar to pregabalin.
Tricyclic antidepressants (amitriptyline, nortriptyline). Long-established evidence for neuropathic pain reduction at low doses (25–100mg at bedtime). Helpful for sleep disruption from neuropathic pain. Significant anticholinergic side effects limit use in elderly patients (dry mouth, constipation, urinary retention, falls risk). Nortriptyline is better tolerated than amitriptyline for most.
Topical capsaicin (8% patch — Qutenza). High-concentration capsaicin applied by a physician under local anesthesia — depletes substance P from peripheral pain fibers, providing 3–6 months of pain relief per application. An option for those unable to tolerate systemic medications. The OTC 0.025–0.075% creams have modest evidence.
Topical lidocaine. 5% lidocaine patches or gel applied to painful areas provide local anesthesia with minimal systemic absorption. Useful for focal areas of allodynia or burning.
Alpha-lipoic acid. An antioxidant with the most evidence of any supplement for DPN — the SYDNEY and ALADIN trials demonstrated reduction in neuropathic symptoms with 600mg IV or oral dosing. Available OTC as a supplement. Not FDA-approved but reasonable to consider as an adjunct, particularly in patients seeking non-pharmacologic options.
The DPN Foot Care Protocol
With DPN, the foot loses its warning system. Pain that would normally alert you to an injury doesn’t arrive. This means the responsibility for foot safety shifts from reflex (pain response) to conscious daily inspection. The DPN foot care protocol is not optional for patients with LOPS — it is the intervention that prevents amputations.
Daily foot inspection. Every single day, examine every surface of both feet — tops, bottoms, between each toe, and the heel. Use a mirror for the plantar surface if you cannot easily see it. Look for: blisters, cuts, abrasions, redness, warmth, swelling, skin breakdown, ingrown toenails, and any change from the previous day. A wound that’s been there for 3 days without your knowledge is far more dangerous than a wound discovered the day it appears.
Moisturize daily. Autonomic neuropathy produces anhidrosis (absent sweating), causing the skin to become dry, cracked, and prone to fissuring — particularly at the heel. Apply moisturizing cream (not between the toes — moisture there promotes fungal growth) daily. Urea-based creams (10–20% urea) are particularly effective for thick, calloused, dry diabetic skin.
Never go barefoot. Ever. Not in your own home, not at the beach, not around the pool. The ground your insensate foot cannot feel may contain glass, rocks, staples, or hot surfaces. Diabetic patients who go barefoot create their own wounds without knowing it.
Appropriate footwear at all times. Diabetic-grade therapeutic footwear with: extra depth to accommodate orthotics and deformities without pressure points, seamless or minimal-seam uppers, wide toe box to prevent toe compression, cushioned insoles to protect insensate plantar skin, and no hard internal seams that can create pressure wounds over bony prominences.
Professional nail and callus care. Do not attempt to trim calluses yourself — a diabetic foot with LOPS and compromised healing should never be subjected to sharp instruments wielded without professional training. Calluses that are too aggressively trimmed or accidentally cut create the entry wound for 80% of diabetic foot infections. See a podiatrist for nail trimming and callus debridement.
Temperature testing. Because LOPS prevents you from feeling burns, test bathwater temperature with your elbow before entering, avoid heating pads and hot water bottles near feet, and be aware of hot pavement (above 120°F in summer sun) and cold outdoor surfaces.
Essential Products for Diabetic Neuropathy
👟 Orthofeet Diabetic Shoes — Therapeutic Extra-Depth Footwear
Medicare-recognized therapeutic footwear for patients with diabetes. Orthofeet builds the specific features that diabetic feet require: extra depth to accommodate swelling and orthotic inserts without pressure points, seamless interior to eliminate rubbing on insensate skin, wide toe box, and anatomical arch support. For patients with LOPS, therapeutic footwear is not a luxury — it is the single most important external protective factor. Orthofeet’s full-grain leather models are appropriate for both medical and casual use.
🧦 Thorlo Diabetic Socks — Padded, Non-Binding
Diabetic socks are not a gimmick — they address the specific vulnerabilities of neuropathic feet. Thorlo’s diabetic-grade socks have: non-binding tops (standard elastic causes circumferential pressure that can restrict circulation in the compromised diabetic foot), seamless toe closures (seams create focal pressure on areas without protective sensation), moisture-wicking fabric (wet feet + neuropathy = maceration + ulceration), and targeted padding under the heel and forefoot. These should replace standard socks for all patients with DPN.
💊 Pure Encapsulations B Complex Plus — B12 Support
Vitamin B12 deficiency — which causes a neuropathy that is clinically indistinguishable from DPN — is significantly more common in diabetic patients on metformin (metformin reduces B12 absorption). The ADA recommends periodic B12 monitoring in all long-term metformin users. Adequate B12 is also necessary for myelin synthesis and nerve repair. Pure Encapsulations B Complex Plus provides methylcobalamin (the most bioavailable B12 form) alongside the full B complex in a hypoallergenic formulation. This is a reasonable supplement for virtually any diabetic neuropathy patient, and essential for those on metformin.
🦶 Powerstep Pinnacle Diabetic Insoles
For patients who are not yet in custom orthotics, the Powerstep Pinnacle provides firm arch support and deep heel cupping to reduce plantar pressure on the vulnerable neuropathic foot. Paired with therapeutic diabetic footwear, a supportive insole reduces peak plantar pressures — the primary biomechanical driver of diabetic foot ulceration. Powerstep makes a specifically designed diabetic version with extra cushioning that fits the extra-depth diabetic shoe profile.
Warning Signs: The DPN Danger Zone
- Any open wound on the foot — regardless of how small. A wound in a diabetic foot with LOPS that has no pain is no less dangerous — it is more dangerous, because you won’t feel it worsening. Any break in the skin on a diabetic neuropathic foot requires evaluation within 24 hours.
- Redness, warmth, or swelling of one foot significantly more than the other — this asymmetric pattern, particularly in the absence of pain, is the classic presentation of acute Charcot neuroarthropathy. Charcot is frequently misdiagnosed as cellulitis. Failure to immobilize immediately results in permanent, progressive foot collapse. Go to a podiatrist or emergency room that same day.
- Skin color changes — black, purple, or blue areas on the toes or foot — possible dry gangrene from vascular insufficiency. This is a limb-threatening emergency. Call vascular surgery or go to the ER.
- Fever with foot swelling or wound — infection with systemic signs requires IV antibiotics and often surgical debridement or drainage. Diabetic foot infections progress to osteomyelitis and sepsis far faster than in non-diabetic patients.
- A wound that is not improving or is getting larger after 2 weeks of treatment — failure to progress in 2 weeks indicates either inadequate offloading, biofilm/infection, ischemia, or an undetected contributing factor (osteomyelitis). Do not wait for a scheduled appointment — call your podiatrist.
When Home Treatment Isn’t Enough
If pain persists beyond 2–3 weeks, it’s time to see a podiatrist. At Balance Foot & Ankle, same-day and next-day appointments are available in Howell and Bloomfield Hills. Dr. Tom Biernacki DPM will identify the exact cause and create a real treatment plan.
Howell: 4330 E Grand River Ave · Bloomfield Hills: 43494 Woodward Ave #208 · Mon–Fri 8 AM–5 PM
Frequently Asked Questions
Can diabetic neuropathy be reversed?
Not significantly, once established. The structural nerve damage — axonal degeneration and demyelination — does not meaningfully reverse even with optimal glycemic control. What can improve: (1) neuropathic pain symptoms often respond to medications and lifestyle interventions, (2) some metabolic contributions to neuropathy (B12 deficiency, thyroid dysfunction) may have reversible components when treated, and (3) very early-stage DPN in younger patients with excellent glycemic optimization may show some small-fiber recovery on repeat biopsy. The practical message: the earlier you optimize glucose control, the less nerve damage accumulates — but do not expect established neuropathy to reverse.
Is it normal to have no symptoms with diabetic neuropathy?
Yes — and this is the insidious aspect of DPN. Up to 50% of patients with significant nerve damage on objective testing report minimal or no pain. The absence of symptoms does not mean the absence of neuropathy — it may mean the patient has progressed beyond the painful phase and entered the truly dangerous phase of asymptomatic LOPS. This is why annual monofilament testing and vibration testing are essential regardless of symptoms.
Can exercise help diabetic neuropathy?
Yes — exercise has multiple mechanisms of benefit in DPN. Aerobic exercise improves insulin sensitivity and glycemic control (addressing the root cause), improves peripheral vascular function (addressing the microvascular component), reduces inflammation, and may directly promote nerve fiber regeneration and maintenance through BDNF (brain-derived neurotrophic factor) release. Multiple randomized controlled trials show significant improvement in neuropathic pain and nerve conduction with regular aerobic exercise. The challenge: patients with significant sensory loss need safe exercise programs that avoid trauma to insensate feet — swimming, cycling, and seated exercises are preferable to high-impact activities.
Does metformin cause neuropathy?
Metformin does not directly cause neuropathy. However, long-term metformin use reduces vitamin B12 absorption by competing for the ileal B12 uptake pathway. B12 deficiency, if not detected and corrected, causes a neuropathy that is additive to diabetic neuropathy. The ADA recommends annual B12 monitoring for patients on long-term metformin. If B12 is low or low-normal, supplementation — typically with methylcobalamin — is appropriate.
Frequently Asked Questions
What are the first signs of diabetic neuropathy in the feet?
Early signs: numbness or reduced sensation starting in the toes, tingling or “pins and needles” sensations, burning pain especially at night, and hypersensitivity to light touch. Some patients lose sensation gradually without pain. Regular monofilament testing by a podiatrist detects neuropathy before symptoms appear.
Can diabetic neuropathy be reversed?
Peripheral neuropathy caused by diabetes cannot be fully reversed, but progression can be slowed significantly with tight blood sugar control (target HbA1c <7%), regular foot care, and treatment of associated conditions. Some patients see partial improvement with glucose optimization early in the disease course.
How is diabetic neuropathy treated?
Management focuses on: blood sugar control to slow progression, pain management (duloxetine, gabapentin, topical capsaicin or lidocaine), protective footwear and custom orthotics to prevent ulcers, regular podiatric monitoring, and fall prevention strategies.
How often should a diabetic see a podiatrist?
The American Diabetes Association recommends diabetic patients with neuropathy or peripheral arterial disease see a podiatrist every 2–3 months. Those without complications should have a foot exam at least annually. High-risk patients (prior ulcers, amputations) are seen monthly.
Does insurance cover diabetic foot care?
Yes. Medicare covers therapeutic shoe fitting, custom insoles, and routine foot care for qualifying diabetics with documented neuropathy or circulation problems. Balance Foot & Ankle is a Medicare-participating provider — call (810) 206-1402 for diabetic foot care.
The Bottom Line
Diabetic peripheral neuropathy is a progressive, partially preventable complication of diabetes with profound implications for foot health and amputation risk. The most important interventions are early: optimize blood sugar before nerve damage accumulates, screen for neuropathy annually with monofilament testing, and implement the daily foot care protocol the moment any loss of protective sensation is detected.
For painful DPN, duloxetine and pregabalin are first-line FDA-approved options, with gabapentin and TCAs as established alternatives. Alpha-lipoic acid and B12 supplementation are reasonable adjuncts. None of these treatments reverse nerve damage — they manage symptoms while you protect the remaining nerves from further insult.
If you have diabetes and have not had a formal podiatric evaluation that includes monofilament testing, vibration testing, and a vascular assessment, schedule one. It’s the single most effective thing you can do today to prevent the cascade that leads to diabetic foot ulceration and amputation.
Sources
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986.
- Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154.
- Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962.
- Tesfaye S, Vileikyte L, Rayman G, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;27(7):629–638.
- Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid. Diabetologia. 1995;38(12):1425–1433.
- Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375.
Diabetes and Foot Concerns? Don’t Wait.
Annual diabetic foot exams, monofilament testing, therapeutic footwear fitting, and wound care. Protecting your feet protects your independence.
Howell: (810) 206-1402
Bloomfield Hills: (810) 206-1402
4.9★ | 1,123+ Reviews | 3,000+ Surgeries | Balance Foot & Ankle
Related Articles from Dr. Biernacki
- Diabetic Foot Care: Prevention, Ulcers, Charcot & When to See a Podiatrist
- Neuropathy in Feet: Which Type You Have Determines Treatment
- Diabetic Foot Ulcer Treatment: Wound Care & Offloading
- Diabetic Foot Wound Care: Complete Guide to Healing
- Best Orthotics for Diabetic Foot 2026
- Best Shoes for Diabetic Neuropathy 2026
📋 Dr. Tom Biernacki, DPM, FACFAS answers:
Diabetic peripheral neuropathy is the foot condition I spend the most time educating patients about because the consequences of unmanaged neuropathy — foot ulcers, infections, and amputation — are entirely preventable with proper care, yet they remain devastatingly common. The fundamental problem neuropathy creates for the foot is loss of protective sensation: the foot can be injured by a pebble in the shoe, a blister from new footwear, or a thermal burn from hot pavement, and the patient feels nothing until the damage is already significant. My approach to neuropathy management has three pillars. First, optimizing glycemic control with the endocrinology team — nothing slows neuropathy progression more effectively than keeping HbA1c below 7%. Second, symptom management for painful neuropathy: I work closely with primary care to optimize medication regimens, typically starting with duloxetine or gabapentin and adjusting based on response and tolerability. Third — and this is what I contribute most directly — comprehensive foot protection protocol. This means diabetic footwear with adequate depth and cushioning, seamless moisture-wicking socks, daily foot inspection with a mirror for spots the patient cannot see, and scheduled podiatric visits every 2 to 3 months rather than annually. A diabetic patient with neuropathy who sees me regularly, follows the foot care protocol, and maintains good glycemic control can live their entire life without a foot ulcer. The same patient who skips check-ups and wears whatever shoes feel comfortable is playing with very serious odds.
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.